Research News

Glitazones are associated with reduced risk of Parkinson’s disease

BMJ 2015; 351 doi: https://doi.org/10.1136/bmj.h3949 (Published 22 July 2015) Cite this as: BMJ 2015;351:h3949
  1. Zosia Kmietowicz
  1. 1London

Patients who take the antidiabetes drugs rosiglitazone or pioglitazone have a lower risk of developing Parkinson’s disease than patients taking other drugs for diabetes, a study published in PLoS Medicine indicates.1

Researchers from the London School of Hygiene and Tropical Medicine used electronic health records from the UK Clinical Practice Research Datalink to match …

View Full Text

Sign in

Log in through your institution

Free trial

Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial

Subscribe